Search results for "Keeping tabs"
Spotlight on inpatient hyperglycemia
A new guideline offered recommendations on managing hyperglycemia in hospital patients with or without diabetes. Recent studies looked at the effects of elevated blood glucose levels after surgery and in the ICU.
https://diabetes.acponline.org/archives/2022/07/08/5.htm
8 Jul 2022
Spotlight on tirzepatide
The first glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist was approved by the FDA and analyzed by a number of recent studies.
https://diabetes.acponline.org/archives/2022/06/10/5.htm
10 Jun 2022
Spotlight on efficacy of SGLT-2 inhibitors and GLP-1 receptor agonists
One recent study compared sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists to each other, a meta-analysis tried to quantify their benefits compared to placebo, and a third study looked at their effects relative to insulin.
https://diabetes.acponline.org/archives/2022/05/13/5.htm
13 May 2022
Spotlight on diabetes after COVID-19
A cohort study in U.S. veterans and a retrospective analysis in Germany found higher risk for incident diabetes in patients who had had COVID-19.
https://diabetes.acponline.org/archives/2022/04/08/5.htm
8 Apr 2022
Spotlight on exercise
Sports medicine experts updated their recommendations on exercise in type 2 diabetes, while a study found that physical activity was associated with lower dementia risk in patients with new type 2 diabetes, and another found that exercise might be more beneficial in the afternoon than the morning.
https://diabetes.acponline.org/archives/2022/03/11/5.htm
11 Mar 2022
Spotlight on the gut microbiome
A Finnish study found that certain gut bacteria were more common in people who later developed type 2 diabetes, while an Israeli study identified a distinct microbial signature in adults with type 1 diabetes compared with healthy controls.
https://diabetes.acponline.org/archives/2022/02/11/5.htm
11 Feb 2022
Spotlight on cardiovascular risk in type 2 diabetes
The American Heart Association released a scientific statement on managing cardiovascular (CV) risk factors, while recent research focused on CV mortality in patients with diabetes and nonalcoholic fatty liver disease and CV outcomes in high-risk patients who take sodium-glucose cotransporter-2 inhibitors.
https://diabetes.acponline.org/archives/2022/01/14/5.htm
14 Jan 2022
Spotlight on body weight and diabetes complications
A systematic review found that weight gain was associated with increased cardiovascular risk in type 2 diabetes patients but that the effects of intentional weight loss were unclear, while another analysis found that higher body mass index was mostly not associated with cancer mortality.
https://diabetes.acponline.org/archives/2021/12/10/5.htm
10 Dec 2021
Spotlight on dementia and glycemic control
Prediabetes and diabetes were associated with development of dementia in a South Korean study, and poorly controlled diabetes was tied to increased risk of incident cognitive impairment or progression to dementia in a Swedish study.
https://diabetes.acponline.org/archives/2021/11/12/5.htm
12 Nov 2021
Spotlight on glycemic control during the pandemic
Several new studies showed that among patients with type 1 diabetes, glycemic control improved and diabetic ketoacidosis decreased during COVID-19 lockdowns, while patients with type 2 diabetes showed the opposite trend during the pandemic.
https://diabetes.acponline.org/archives/2021/10/08/5.htm
8 Oct 2021